Our data suggested that inhibition of MET and AXL phosphorylation activities through LY2801653 in turn led to marked suppression of downstream oncogenic signaling pathways, which might play important roles in proliferation and angiogenesis‐related behaviors of cancer. This evidence concerns the gene AXL and cancer.